Duos Technologies Group Sets Fourth Quarter and Full Year 2023 Earnings Call
Duos Technologies Group Sets Fourth Quarter and Full Year 2023 Earnings Call for Monday, April 1, 2024 at 4:30 PM ET
March 18, 2024 08:00 ET | Duos Technologies Group, Inc
Duos Technologies Group Sets Fourth Quarter and Full Year 2023 Earnings Call for Monday April 1, 2024 at 4:30 PM ET
Paul Mueller Company Logo
Paul Mueller Company Announces Its Fourth Quarter Earnings of 2023
March 15, 2024 16:05 ET | Paul Mueller Company
SPRINGFIELD, Mo., March 15, 2024 (GLOBE NEWSWIRE) -- Paul Mueller Company (OTC: MUEL) today announced earnings for the quarter ended December 31, 2023.              PAUL MUELLER COMPANYTWELVE-MONTH...
Rani-Logo.jpg
Rani Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results
March 15, 2024 16:05 ET | Rani Therapeutics, LLC
SAN JOSE, Calif., March 15, 2024 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral...
Telos2010_2C_web.jpg
Telos Corporation Announces Substantial Progress on New Business Capture; Reports Fourth Quarter and Full Year 2023 Results Above Expectations
March 15, 2024 08:01 ET | Telos Corporation
Telos’ Prime Partners Received Awards on New Programs Worth up to $525 Million to Telos’ Security Solutions Business Over Five Years, Subject to Customary Protest Periods and Favorable Resolution of...
XOS_black_wordmark.png
Xos, Inc. Announces Fourth Quarter and Full Year 2023 Earnings Release Date and Conference Call
March 14, 2024 18:01 ET | Xos, Inc.
LOS ANGELES, March 14, 2024 (GLOBE NEWSWIRE) -- Xos, Inc. (NASDAQ: XOS), a leading electric truck manufacturer and fleet services provider, announced it will release its fourth quarter and full year...
Logo 400x400.jpg
CytoSorbents Reports Fourth Quarter and Full Year 2023 Results
March 14, 2024 16:39 ET | CytoSorbents
CytoSorbents Reports Fourth Quarter and Full Year 2023 Results
Evoke Pharma, Inc.
Evoke Pharma Reports Fourth Quarter and Full Year 2023 Financial Results
March 14, 2024 16:05 ET | Evoke Pharma, Inc.
Fiscal year 2023 net product sales from prescriptions totaled approximately $5.2M, a 107% increase from 2022 Company projects $14M in net revenue for 2024 SOLANA BEACH, Calif., March 14, 2024 ...
Kandi Technologies Reports 2023 Financial Results
March 14, 2024 16:05 ET | Kandi Technologies Group, Inc.
Please process, send us a draft link and cc filings@edgaragents.com, and KEEP ON HOLD. Thank you.
Atyr_Logo.png
aTyr Pharma Announces Fourth Quarter and Full Year 2023 Results and Provides Corporate Update
March 14, 2024 16:00 ET | aTyr Pharma, Inc.
aTyr Pharma Announces Fourth Quarter and Full Year 2023 Results and Provides Corporate Update
60da41518104f75c070f1afa_1.png
Golden Matrix Reports First Quarter Financial Results With Record Revenues of $11.84 Million
March 14, 2024 09:15 ET | Golden Matrix Group Inc,
LAS VEGAS, NV, March 14, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – Golden Matrix Group Inc. (NASDAQ:GMGI), developer, licensor and global operator of online gaming and eCommerce platforms, systems...